Skip to main content
. 2016 Aug 15;5(8):e253. doi: 10.1038/oncsis.2016.47

Figure 5.

Figure 5

shRNA knockdown of RCAN2 in the Colo320 human colorectal cancer cell line. RCAN2 expression in Colo320 cells (both KRAS and wild-type BRAF) with high expression of RCAN2 was knocked down using an shRNA vector. RCAN2 expression (a) and calcineurin activity (b) were compared between cells infected with pSUPER/RCAN2 1, 2 and pSUPER/non-silencing. These cells were subjected to proliferation and wound-scratch migration assays (c, d, respectively). In vivo tumorigenesis was compared between Colo320 cells infected with pSUPER/RCAN2 1 and pSUPER/non-silencing using a xenograft subcutaneous transplantation model in order to determine tumor volume (e) and tumor weight (f). Images of harvested tumors are shown in g.